Raised erythrocyte sedimentation rate in asymptomatic hyperlipidaemia

Area of Science:

• Clinical Biochemistry
• Cardiovascular Medicine
• Hematology

Background:

• Hyperlipidaemia is a significant risk factor for cardiovascular disease.
• Elevated erythrocyte sedimentation rate (E.S.R.) is a common indicator of inflammation.
• The relationship between hyperlipidaemia and E.S.R. requires further investigation.

Purpose of the Study:

• To investigate the erythrocyte sedimentation rate (E.S.R.) in hyperlipidaemic individuals.
• To explore potential mechanisms linking hyperlipidaemia to elevated E.S.R.
• To assess the association between E.S.R. levels and silent ischemic heart disease in hyperlipidaemic patients.

Main Methods:

• Studied 101 hyperlipidaemic subjects and compared E.S.R. with normolipidaemic controls.
• Analyzed plasma lipoprotein levels, cholesterol, triglycerides, and lysolecithin concentrations.
• Assessed the incidence of ischemic exercise E.C.G. changes in relation to E.S.R. levels.

Main Results:

• Significantly higher E.S.R. was observed in hyperlipidaemic subjects compared to controls.
• E.S.R. elevation was noted in 44%, 64%, and 23% of subjects with hyperlipoproteinaemia types II A, II B, and IV, respectively.
• No correlation was found between E.S.R. and plasma lipoprotein levels or lysolecithin.
• Ischemic E.C.G. changes were more frequent in hyperlipidaemic subjects with higher E.S.R. (72% vs. 38%).

Conclusions:

• Hyperlipidaemia is associated with elevated E.S.R. in otherwise healthy individuals.
• The elevated E.S.R. in hyperlipidaemia may be a marker for underlying silent vascular disease.
• Further research is warranted to elucidate the precise mechanisms and clinical implications.